CFTR and cystic fibrosis: Despite the uncertainties regarding lubiprostone's mechanism of action, there were significant changes in lubiprostone treated CF mice which demonstrate that lubiprostone has CFTR independent effects in the mouse small intestine that are beneficial to the CF phenotype.